SECURE (H2020 Health project): Secondary prevention of cardiovascular disease in the elderly

SECURE will evaluate whether Trinomia® will reduce the rate of death from cardiovascular (CV) causes, nonfatal myocardial infarction (MI), stroke, and hospitalisation requiring revascularisation when compared to treatments where the patients have to take several drugs separately, in patients over 65, in several European countries with different rates of adherence and CV events (Spain, Italy, France, Hungary, Poland, Germany and the Czech Republic). Through pharmacoeconomic measures SECURE will also aim to prove that the FDC polypill is a cost- effective strategy in the prevention of cardiovascular disease (CVD). Additionally, regional differences in terms of adherence rates, risk factor control and CV events will also be studied in order to aid the different stakeholders in making appropriate decisions that are specific for each region.

These comments are moderated. Your comment will not be visible unless accepted by the content owner.

Only simple HTML formatting is allowed and any hyperlinks will be stripped away. If you need to include a URL then please simply type it so that users can copy and paste it if needed.

Note: Only shown to the creator of the post